Funding Rounds
Be Biopharma Series A round, October 2020
Be BiopharmaBe Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.
Summary
Stage: Series A
Raised Amount: $52.00M
Raised Date: 2020-10-26
